NOMOTHETICOS: Nonlinear Modelling of Thyroid Hormones' Effect on Thyrotropin Incretion in Confirmed Open-loop Situation

Sponsor

Ruhr University of Bochum (Other)

Overall Status

Active, not recruiting

CT.gov ID

NCT01145040

Collaborator

(none)

138

Enrollment

Locations

128

Anticipated Duration (Months)

Patients Per Site

0.4

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The NOMOTHETICOS study is a unicentric cross-sectional study for a quantitative analysis of feedback-inhibition in the thyrotropic homeostatic control. Structural parameters are obtained in vivo from open-loop analysis in patients with disconnected feedback, i.e. with overt thyroid dysfunction or full dose substitution therapy with levothyroxine.

Condition or Disease	Intervention/Treatment	Phase
Hypothyroidism Hyperthyroidism

Detailed Description

Control of thyroid hormone homeostasis is essential for function and development of the organism and hence for individual health. It is therefore not surprising that the thyroid's function is controlled by a complex, multi-loop feedback control system.

Today, the central component of the thyrotropic feedback control system is still poorly understood on a physiological level. Therefore, in mathematical models different functional relations describing the feedback-inhibition of thyrotropin incretion by thyroid hormones have been suggested [Danziger and Elmergreen 1956, Roston 1959, Norwich and Reiter 1965, DiStefano and Stear 1968, DiStefano 1969, Saratchandran et al. 1973, Li et al. 1995, Dietrich et al. 2004, Degon et al. 2008, Jonklaas and Soldin 2008, Hörmann et al. 2010]. Most of these models fail in delivering biochemical explanations for the functional interrelations they postulate.

Nevertheless, some clinical applications of these models have been developed, although their diagnostical potential is usually rather limited [Yagi et al. 1997, Pohlenz et al. 1999, Jostel et al. 2009].

Assuming that the pituitary's response to peripheral thyroid hormones is determined by active transmembrane thyroxine transport mechanisms [Dietrich et al. 2008], intracellular deiodination of thyroxine (T4), binding of resulting triiodothyronine (T3) to iodothyronine receptors and, finally, their inhibiting effect on mRNA expression, translation and release of TRH, a novel, physiologically motivated model has been developed that is based on compartment-analytical approaches, Michaelis-Menten kinetics and non competitive divisive inhibition [Dietrich et al 2004]. However, this model has not been sufficiently evaluated in a clinical context.

It is the aim of the NOMOTHETICOS study to deliver new systems-level insights into the pituitary's thyrotropic function. This unicentric cross-sectional study compares different models of feedback-inhibition by means of modern statistical methods like nonlinear regression and Akaike information criterion. Structural parameters are obtained in vivo from open-loop analysis in patients with disconnected feedback in equilibrium.

These parameters can serve as theoretical basis for possible future trials developing advanced diagnostical evaluation methods of thyrotropic pituitary function.

Study Design

Study Type:

Observational

Actual Enrollment :

138 participants

Observational Model:

Cohort

Time Perspective:

Cross-Sectional

Official Title:

NOMOTHETICOS: Nonlinear Modelling of Thyroid Hormones' Effect on Thyrotropin Incretion in Confirmed Open-loop Situation. A Correlation Study

Actual Study Start Date :

Jun 1, 2010

Actual Primary Completion Date :

Jul 31, 2018

Anticipated Study Completion Date :

Jan 31, 2021

Arms and Interventions

Arm	Intervention/Treatment
Partition 1 Overt primary hypothyroidism
Partition 2 Hypothyroidism with "full dose" levothyroxine substitution therapy (more than 1.75 µg per kg of body mass)
Partition 3 Overt primary hyperthyroidism

Outcome Measures

Primary Outcome Measures

Nonlinear correlation of thyrotropin levels with peripheral levothyroxine levels. [Data of individual patients are obtained one work day after consultation (to allow for laboratory investigations). Model comparison will take place immediately after the inclusion of the 100th patient.]
Nonlinear modeling of the pituitary response with different models (logarithmic, polynomial, non-competitive divisive inhibition). Selection of one out of different possible mathematical models that suffices an optimal combination of best nonlinear fit (minimal p-value), minimal entropy (as expressed by minimal values for Akaike information criterion, Bayesian information criterion and Hannan-Quinn information criterion) and best compatibility with biochemical mechanisms.

Secondary Outcome Measures

Parameters of feedback inhibition. [Data of individual patients are obtained one work day after consultation (to allow for laboratory investigations). Parameter estimation will take place immediately after the inclusion of the 100th patient.]
Extraction of structural parameters out of the model that has been selected (see primary outcome measure)

Eligibility Criteria

Criteria

Ages Eligible for Study:

14 Years and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

Outpatients with disconnected feedback control due to the following conditions:
Overt primary hypothyroidism with TSH level higher than 10 mU/l and FT4 concentration below 7 pmol/L (5.4 ng/L) (Partition 1)
Overt primary hyperthyroidism with TSH level below 0.1 mU/l and FT4 concentration higher than 18 pmol/L (14 ng/L) (Partition 3)
All other constellations, if the patient receives substitution therapy with more 1.75 µg Levothyroxin per kg of body mass (Partition 2).
System in equilibrium (e.g. unchanged substitution dose over the past six weeks)

Exclusion Criteria:

Pituitary or hypothalamic dysfunction
Severe illness that may be associated with euthyroid sick syndrome (non-thyroidal illness syndrome)
Medication influencing pituitary function
Pregnancy
Missing consent for participation in the study

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Klinikum Ludwigsburg-Bietigheim	Bietigheim	BW	Germany	D-74321
2	Institute for diagnostical radiology, interventional radiology and nuclear medicine, Bergmannsheil University Hospitals, Ruhr University of Bochum	Bochum	NRW	Germany	D-44789
3	Medical Hospital I, Bergmannsheil University Hospitals, Ruhr University of Bochum	Bochum	NRW	Germany	D-44789

Sponsors and Collaborators

Ruhr University of Bochum

Investigators

Principal Investigator: Johannes W Dietrich, M.D., Medical Hospital I, Bergmannsheil University Hospitals, Ruhr University of Bochum
Study Chair: Harald H Klein, M.D., Medical Hospital I, Bergmannsheil University Hospitals, Ruhr University of Bochum
Study Director: Johannes W Dietrich, M.D., Medical Hospital I, Bergmannsheil University Hospitals, Ruhr University of Bochum
Principal Investigator: Bojana Bazika-Gerasch, M.D., Medical Hospital I, Bergmannsheil University Hospitals, Ruhr University of Bochum